Treatment
Clinically proven, home-based care guided by clinicians
Short heading
Flow delivers non-invasive brain stimulation to support remission from depression, with tools for seamless monitoring and personalisation.
Backed by neuroscience
Designed for real-world care
Flow uses transcranial direct current stimulation (tDCS) to modulate brain activity in the dorsolateral prefrontal cortex—an area consistently underactive in depression. The result: enhanced neuroplasticity, improved mood regulation, and better treatment outcomes.
Simple schedule
Predictable outcomes.
Flow follows a structured 12-week protocol with built-in flexibility.
- Initial device setup
- 30 minute daily sessions/5 days a week
- Tracking initial responses and adjustments
- 2-3 stimulation sessions per week
- Consolidates and sustains improvements
Clinicians can personalise schedules based on patient response, with real-time adjustments via the Flow Clinician Platform.
Proven reduction in
symptoms by week 6–10.
Patients track their progress using the MADRS-s within the Flow app.
Average symptom reduction (points by week 10)
Adherence in early treatment weeks
Engagement with mobile guidance
Built for patients, and clinicians.
Flow supports safe and effective implementation across a variety of settings:
- Standalone or adjunct to medication or therapy
- Easy onboarding with a 10-minute patient start-up
- Clinician dashboard for tracking, reviewing and adjusting protocols
- Dedicated clinical support for complex case consultations
Everything you need to succeed with Flow
A short text about this section if needed. It’s not neccessary, but it’s available to make it more inviting and descriptive.
